NMTR Research and Charts

NMTR - 9 Meters Biopharma Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-02-09 (Delayed quote data 2025-06-24)

Last 0.00	Change ⇓ 0.00 (0.00%)	Volume 3,025
	Open 0.00	High 0.00	Low 0.00

8EMA (Daily) 0.00	40EMA (Daily) 0.00	50EMA (Daily) 0.00	STO (Daily) 0.000	MACD Hist (Daily) 0.000
8EMA (Weekly) 0.000	40EMA (Weekly) 0.01	50EMA (Weekly) 0.02	STO (Weekly) 0.000	MACD Hist (Weekly) 0.002


Company Profile
9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003 and others.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.